SBP as high as 241 recorded.
She was given hydral 20 IV without improvement, so she was placed on a Labetalol gtt @ 4 mg/min with improvement of SBP 220.
She was given IV Zofran, IV dilaudid, Hydralazine 50mg po, Labetolol 200mg po, Labetolol 100mg IV x 3, Levofloxacin 750mg IV, Ceftriaxone 1g IV, Vancomycin 1g IV, weregiven for question of infiltrate on CXR prior to CT. Nitroprusside gtt added and .5 mg/kg, pressure initially improved to 180s.
Pan-scan w/o contrast showed interval worsening of chronic pulmonary edema.
One blood culture was sent in the ED.
Per report, EKG showed LVH, ST depression in V6.
She continued to complain of abdominal pain and shortness of breath though her chest discomfort was improved.
Systemic lupus erythematosus: - Diagnosed [**2134**] (16 years old) when she had swollen fingers, arm rash and arthralgias - Previous treatment with cytoxan, cellcept; currently on prednisone - Complicated by uveitis ([**2139**]) and ESRD ([**2135**]) 2.
CKD/ESRD: - Diagosed [**2135**] - Initiated [**Year (4 digits) 2286**] [**2137**] but refused it as of [**2140**], has survived despite this - PD catheter placement [**5-18**] 3.
Malignant hypertension - Baseline BPs 180's - 120's - History of hypertensive crisis with seizures - History of two intraparenchymal hemorrhages that were thought due to the posterior reversible leukoencephalopathy syndrome, associated with LE paresis in [**2140**] that resolved 4.
Thrombotic events: - SVC thrombosis ([**2139**]); related to a catheter - Negative lupus anticoagulant ([**4-/2138**], [**8-/2138**], [**9-/2140**]) - Negative anticardiolipin antibodies IgG and IgM x4 ([**2137**]-[**2140**])  - Negative Beta-2 glycoprotein antibody ([**4-/2138**], [**8-/2140**]) 6.
HOCM: Last noted on echo [**8-17**] 7.
Obstructive sleep apnea, AutoCPAP/ Pressure setting [**5-20**], Straight CPAP/ Pressure setting 7 13.
Lungs- CTA bilat Abd- + BS, soft, ND.
Pertinent Results: Admission Labs:  [**2142-3-21**] 02:20AM   WBC-5.0 RBC-2.61* HGB-7.7* HCT-23.5* MCV-90 MCH-29.4 MCHC-32.6 RDW-19.3* [**2142-3-21**] 02:20AM   NEUTS-76.1* BANDS-0 LYMPHS-17.9* MONOS-4.5 EOS-1.1 BASOS-0.5 [**2142-3-21**] 02:20AM   PLT SMR-NORMAL PLT COUNT-168 [**2142-3-21**] 02:20AM   PT-21.8* PTT-34.7 INR(PT)-2.1* [**2142-3-21**] 02:20AM   cTropnT-0.12* [**2142-3-21**] 02:20AM   ALT(SGPT)-46* AST(SGOT)-94* CK(CPK)-76 ALK PHOS-173* TOT BILI-0.4 [**2142-3-21**] 02:20AM   GLUCOSE-74 UREA N-47* CREAT-7.3* SODIUM-140 POTASSIUM-5.8* CHLORIDE-109* TOTAL CO2-19* ANION GAP-18 [**2142-3-21**] 04:00AM URINE  BLOOD-TR NITRITE-NEG PROTEIN-100 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-8.0 LEUK-NEG [**2142-3-21**] 08:00AM URINE  BLOOD-SM NITRITE-NEG PROTEIN-500 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 LEUK-NEG [**2142-3-21**] 12:58PM   CK-MB-NotDone cTropnT-0.12* .
CT C/A/P - [**2142-3-20**] - 1.
The study and the report were reviewed by the staff radiologist.
Discharge labs:  [**2142-3-23**] 12:00PM BLOOD WBC-3.7* RBC-2.87* Hgb-8.7* Hct-26.1* MCV-91 MCH-30.3 MCHC-33.3 RDW-19.4* Plt Ct-130* [**2142-3-23**] 12:00PM BLOOD Plt Ct-130* [**2142-3-23**] 12:00PM BLOOD PT-28.8* PTT-58.6* INR(PT)-2.9* [**2142-3-23**] 12:00PM BLOOD Glucose-77 UreaN-31* Creat-6.0*# Na-137 K-4.8 Cl-104 HCO3-24 AnGap-14 [**2142-3-23**] 12:00PM BLOOD Calcium-8.4 Phos-5.7* Mg-1.9  Brief Hospital Course: This is a 24 y.o F with SLE, ESRD on HD and malignant hypertension  presenting with abd pain, diarrhea, and HTN.
Initial attempts were made to control her BP with hydralazine and labetalol IV but after these failed to control her blood pressure, she was started on a labetalol and nitroprusside drip and admitted to the ICU.
This was then changed to a nicardipine drip.
CT prelim neg for small bowel obstruction.
On arrival to the floor, abd pain was back to baseline and well controlled on Dilaudid 2mg PO q 4hrs .
[**Month/Year (2) **]:*30 Tablet(s)* Refills:*2* 8.
BP 110's/80's   Discharge Instructions: You were admitted with hypertension and abdominal pain.
You should also get a repeat urinalysis and urine culture if you have any UTI symptoms.
